Impact of Ovarian Cancer Surgery Volume on Overall and Progression-Free Survival: A Population-Based Retrospective National French Study Pauline ProstMartha DuraesGauthier Rathat Gynecologic Oncology 23 February 2024 Pages: 3269 - 3279
Quality of Life After Extended Pelvic Surgery with Neurovascular or Bony Resections in Gynecological Oncology: A Systematic Review Andreas DenysSofie ThielemansGabrielle H. van Ramshorst Gynecologic Oncology 08 March 2024 Pages: 3280 - 3299
ASO Visual Abstract: Prediction of Recurrent Cervical Cancer in 2 Years Follow-Up After Treatment Based on Quantitative and Qualitative Magnetic Resonance Imaging Parameters—A Preliminary Study Jie LiuShujian LiJingliang Cheng ASO Visual Abstract 03 February 2024 Pages: 3300 - 3301
Assessment of Social Vulnerabilities of Care and Prognosis in Adult Ocular Melanomas in the US Joshua A. MensahDavid J. Fei-ZhangDustin D. French Melanoma 28 February 2024 Pages: 3302 - 3313
Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative Nadege T. FackcheRyan K. SchmockerJonathan B. Greer Peritoneal Surface Malignancy 03 February 2024 Pages: 3314 - 3324
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study Alexis TrecourtNaoual Bakrinthe RENAPE Group Peritoneal Surface Malignancy Open access 10 February 2024 Pages: 3325 - 3338
Venous Thromboembolism in Peritoneal Mesothelioma: Uncovering the Hidden Risk Varun V. BansalOwen MitchellKiran K. Turaga Peritoneal Surface Malignancy 19 February 2024 Pages: 3339 - 3349
Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis on Perioperative and Oncologic Outcomes Valentina GhirardiRita TrozziAnna Fagotti Peritoneal Surface Malignancy Open access 27 February 2024 Pages: 3350 - 3360
ASO Visual Abstract: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study Alexis TrecourtNaoual Bakrinthe RENAPE Group ASO Visual Abstract 09 February 2024 Pages: 3361 - 3363
ASO Visual Abstract: Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Non-gynecologic Cancers Shannon N. RadomskiMatthew DunworthAndrew J. Ewald ASO Visual Abstract 13 January 2024 Pages: 3364 - 3365
Review: Implant-Based Breast Reconstruction After Mastectomy for Breast Cancer: A Meta-analysis of Randomized Controlled Trials and Prospective Studies Comparing Use of Acellular Dermal Matrix (ADM) Versus Without ADM Trina Priscilla NgBrandon Yong Kiat LooVisnu Lohsiriwat Reconstructive Oncology 29 January 2024 Pages: 3366 - 3376
Remote Symptom Monitoring with Clinical Alerts Following Mastectomy: Do Early Symptoms Predict 30-Day Surgical Complications Jacqueline J. ChuAudree B. TadrosJonas A. Nelson Reconstructive Oncology 14 February 2024 Pages: 3377 - 3386
ASO Visual Abstract: Early Complications in Prepectoral Tissue Expander-Based Breast Reconstruction Robyn N. RubensteinMinji KimJonas A. Nelson ASO Visual Abstract 19 February 2024 Pages: 3387 - 3388
Comparing Multivisceral Resection with Tumor-only Resection of Liposarcoma Using the Win Ratio Leva GorjiMelica NikahdJoal D. Beane Sarcoma Open access 12 February 2024 Pages: 3389 - 3396
ASO Author Reflections: Multivisceral Versus Tumor-Only Resection in Retroperitoneal Liposarcoma Amblessed OnumaLeva GorjiJoal D. Beane ASO Author Reflections Open access 26 February 2024 Pages: 3397 - 3398
Clinical and Pathologic Supraclavicular Lymph Node Metastases in Esophageal Squamous Cell Carcinoma Treated by Esophagectomy with Three-Field Lymph Node Dissection Seong Yong ParkJunghee LeeYoung Mog Shim Thoracic Oncology 12 December 2023 Pages: 3399 - 3408
Treatment Patterns and Postoperative Activities of Daily Living in Patients with Non-small Cell Lung Cancer: A Retrospective Study Using Nationwide Health Services Utilization Data in Japan Ayako OkuyamaTomonori MizutaniAsao Ogawa Thoracic Oncology 21 December 2023 Pages: 3409 - 3416
Absence of Hypercoagulation Status after Neoadjuvant Treatment is Associated with Favorable Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma Fumitake SugiyamaMitsuro KandaYasuhiro Kodera Thoracic Oncology 20 January 2024 Pages: 3417 - 3425
Multimodality Management of Thoracic Tumors: Initial Experience With a Multidisciplinary Thoracic Ablation Conference Alexander GraurJonathan A. SaengerFlorian J. Fintelmann Thoracic Oncology 25 January 2024 Pages: 3426 - 3436
Clinical Impact of Conversion Surgery After Induction Therapy for Esophageal Cancer with Synchronous Distant Metastasis: A Multi-institutional Retrospective Study Keijiro SugimuraKoji TanakaYuichiro Doki Thoracic Oncology 01 February 2024 Pages: 3437 - 3447
Surgical Outcomes in Non-Small Cell Lung Cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis Sohee ParkJooae ChoeJoon Beom Seo Thoracic Oncology 22 February 2024 Pages: 3448 - 3458
Prediction of Morbidity and Mortality After Esophagectomy: A Systematic Review M. P. van Nieuw AmerongenH. J. de GroothP. R. Tuinman Thoracic Oncology Open access 21 February 2024 Pages: 3459 - 3470
ASO Author Reflections: Prediction of Morbidity and Mortality After Esophagectomy: A Systematic Review M. P. van Nieuw AmerongenH. J. de GroothP. R. Tuinman ASO Author Reflections Open access 07 March 2024 Pages: 3471 - 3472
ASO Author Reflections: Association Between Preoperative Coagulation Status and Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma After Neoadjuvant Treatment Fumitake SugiyamaMitsuro KandaYasuhiro Kodera ASO Author Reflections 23 January 2024 Pages: 3473 - 3474
ASO Author Reflections: Clinical Impact of Conversion Surgery After Induction Therapy for Esophageal Cancer with Synchronous Distant Metastasis: A Multi-institutional, Retrospective Study Keijiro SugimuraKoji TanakaYuichiro Doki ASO Author Reflections 24 February 2024 Pages: 3475 - 3476
ASO Visual Abstract: Absence of Hypercoagulation Status After Neoadjuvant Treatment is Associated with Favorable Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma Fumitake SugiyamaMitsuro KandaYasuhiro Kodera ASO Visual Abstract 29 February 2024 Pages: 3477 - 3478
ASO Visual Abstract: Treatment Patterns and Postoperative Activities of Daily Living in Patients with Non-small Cell Lung Cancer—A Retrospective Study Using Nationwide Health Services Utilization Data in Japan Ayako OkuyamaTomonori MizutaniAsao Ogawa ASO Visual Abstract 24 January 2024 Pages: 3479 - 3480
ASO Visual Abstract: Surgical Outcomes in Non-small Cell Lung Cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis Sohee ParkJooae ChoeJoon Beom Seo ASO Visual Abstract 14 March 2024 Pages: 3481 - 3482
ASO Visual Abstract: Robotic Versus Thoracoscopic Sub-lobar Resection for Octogenarians with Clinical IA-Stage Non-small Cell Lung Cancer: A Propensity Score-Matched Real-World Study Hanbo PanNingyuan ZouQingquan Luo ASO Visual Abstract 22 December 2023 Pages: 3483 - 3484
ASO Visual Abstract: Patients’ Preferences Towards Decision Counseling for Active Surveillance After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Merel HermusCharlène J. van der ZijdenLeonieke W. Kranenburg ASO Visual Abstract 05 January 2024 Pages: 3485 - 3486
ASO Visual Abstract: Prognostic Factors for Recovery from Left Recurrent Laryngeal Nerve Palsy After Minimally Invasive McKeown Esophagectomy: A Retrospective Study Chun-Ting KuoChien-Hung ChiuYin-Kai Chao ASO Visual Abstract 27 December 2023 Pages: 3487 - 3488
ASO Visual Abstract: Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant Chemoradiotherapy Yehan ZhouWenwu HeYang Liu ASO Visual Abstract 13 December 2023 Pages: 3489 - 3490
ASO Visual Abstract: Completely Resectable (cT1-2) Esophageal Squamous Cell Carcinoma with Minimal Lymph Node Involvement (cN1): Is Neoadjuvant Chemoradiation Therapy the Only Viable Treatment Option? Young Ho YangByung Jo ParkDae Joon Kim ASO Visual Abstract 10 January 2024 Pages: 3491 - 3492
Understanding and Applying the Comprehensive Geriatric Assessment as a Frailty Index in Patients Undergoing Esophagectomy Thomas RitchieSri SivarajanBhaskar Kumar Thoracic Oncology 16 February 2024 Pages: 3493 - 3494
BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma Hon-Fan LaiJen-Fan HangChen-Hsen Lee Translational Research 01 February 2024 Pages: 3495 - 3501
COL8A1 Regulates Esophageal Squamous Carcinoma Proliferation and Invasion Through PI3K/AKT Pathway Jing HuPengbo LiSenxiang Yan Translational Research 01 March 2024 Pages: 3502 - 3512
Predicting Recurrence After Radical Surgery for High-Risk Renal Cell Carcinoma: Development and Internal Validation of the “TOWARDS” Score Yudai IshiyamaKenji OmaeToshio Takagi Urologic Oncology 29 January 2024 Pages: 3513 - 3522
A New Nephrometry Score for Predicting Positive Surgical Margin After Laparoscopic Partial Nephrectomy Emin Taha KeskinOsman CanAbdülmuttalip Şimşek Urologic Oncology 31 January 2024 Pages: 3523 - 3530
Gross Hematuria Does not Affect the Selection of Nephrectomy Types for Clinical Stage 1 Clear Cell Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study Zhuo XingHaozhe XuYuan Li Urologic Oncology 08 February 2024 Pages: 3531 - 3543
Intratumoral Heterogeneity, Chemoresistance and Lymph Node Landing Zone Prognosis in Testicular Tumors Based on Histopathological Characteristics Yashasvi SinghSasanka Kumar BaruaNeha Garg Urologic Oncology 21 February 2024 Pages: 3544 - 3553
ASO Author Reflections: Recurrence Risk Prediction in High-Risk Renal Cell Carcinoma: Where We Stand Yudai IshiyamaKenji OmaeToshio Takagi ASO Author Reflections 14 February 2024 Pages: 3554 - 3555
ASO Author Reflections: Clinical Stage I Clear Cell Renal Cell Carcinoma Patients with Gross Hematuria: Radical Nephrectomy or Partial Nephrectomy? Zhuo XingYuan Li ASO Author Reflections 06 February 2024 Pages: 3556 - 3557
Nonlinear Associations of Adipose Tissue Metrics with Short-Term Postoperative Complications in Clear Cell Renal Cell Carcinoma Patients Zehua SunYumei ZhangHeng Ma ASO Author Reflections 06 February 2024 Pages: 3558 - 3559
ASO Visual Abstract: Predicting Recurrence After Radical Surgery for High-Risk Renal Cell Carcinoma: Development and Internal Validation of the ‘TOWARDS’ Score Yudai IshiyamaKenji OmaeToshio Takagi ASO Visual Abstract 02 March 2024 Pages: 3560 - 3560
ASO Visual Abstract: Gross Hematuria Does Not Affect the Selection of Nephrectomy Types for Clinical Stage 1 Clear Cell Renal Cell Carcinoma—A Multicenter Retrospective Cohort Study Zhuo XingHaozhe XuYuan Li ASO Visual Abstract 26 February 2024 Pages: 3561 - 3562
Letter to the Editor for the Article “Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma” Fumihiko UrabeShunsuke TsuzukiTakahiro Kimura Urologic Oncology 09 March 2024 Pages: 3563 - 3564
Reply to: Letter to the Editor for the Article “Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma,” by Urabe, Fumihik et al. Bogomir Milojevic Urologic Oncology 11 March 2024 Pages: 3565 - 3566